Atenolol 50 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Atenolol
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 2000 tablets, 1000 tablets and 120 more
- Manufacturers
- Zydus LifesciencesIndiaIpca LaboratoriesIndiaUnichem LaboratoriesIndiaAurobindo PharmaIndiaA-S Medication SolutionsMylan PharmaceuticalsRising Pharma HoldingsTeva PharmaceuticalsMylan Institutional27 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C07AB03 Atenolol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 January 1992
- Identifiers
- RxCUI 197381, 197379, 197380DailyMed set ID ecfcebcc-8fcd-48e6-871e-151074df3abc, 4fc4a969-286f-4fd2-b16a-f0291fd1c5c0, 25a72ec9-de0f-44e5-90b8-da1aab0d3588 +37NDC 72162-2325, 83008-052, 0093-0752 +37Application ANDA073026, ANDA213136, ANDA074056 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 27 labelers. The register lists 123 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65841-023-01 | Zydus LifesciencesIndia | 8 October 2005 |
| 2000 tablet in 1 bottle | 65841-023-02 | Zydus LifesciencesIndia | 8 October 2005 |
| 1000 tablet in 1 bottle | 65841-023-10 | Zydus LifesciencesIndia | 8 October 2005 |
| 90 tablet in 1 bottle | 65841-023-16 | Zydus LifesciencesIndia | 8 October 2005 |
| 10000 tablet in 1 bottle | 65841-023-24 | Zydus LifesciencesIndia | 8 October 2005 |
| 5000 tablet in 1 bottle | 65841-023-40 | Zydus LifesciencesIndia | 8 October 2005 |
| 100 tablet in 1 bottle | 68382-023-01 | Zydus LifesciencesIndia | 8 October 2005 |
| 2000 tablet in 1 bottle | 68382-023-02 | Zydus LifesciencesIndia | 8 October 2005 |
| 1000 tablet in 1 bottle | 68382-023-10 | Zydus LifesciencesIndia | 8 October 2005 |
| 90 tablet in 1 bottle | 68382-023-16 | Zydus LifesciencesIndia | 8 October 2005 |
| 10000 tablet in 1 bottle | 68382-023-24 | Zydus LifesciencesIndia | 8 October 2005 |
| 5000 tablet in 1 bottle | 68382-023-40 | Zydus LifesciencesIndia | 8 October 2005 |
| 100 tablet in 1 bottle | 65862-169-01 | Aurobindo PharmaIndia | 31 October 2007 |
| 1000 tablet in 1 bottle | 65862-169-99 | Aurobindo PharmaIndia | 31 October 2007 |
| 100 tablet in 1 bottle | 83980-023-01 | Ipca LaboratoriesIndia | 30 January 2026 |
| 1000 tablet in 1 bottle | 83980-023-10 | Ipca LaboratoriesIndia | 30 January 2026 |
| 10 tablet in 1 bottle | 83980-023-97 | Ipca LaboratoriesIndia | 30 January 2026 |
| 100 tablet in 1 bottle | 29300-411-01 | Unichem LaboratoriesIndia | 6 January 2020 |
| 500 tablet in 1 bottle | 29300-411-05 | Unichem LaboratoriesIndia | 6 January 2020 |
| 1000 tablet in 1 bottle | 29300-411-10 | Unichem LaboratoriesIndia | 26 August 2022 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 51079-684-20 | Mylan Institutional | 24 July 1997 |
| 100 tablet in 1 bottle, plastic | 0378-0231-01 | Mylan Pharmaceuticals | 24 January 1992 |
| 1000 tablet in 1 bottle, plastic | 0378-0231-10 | Mylan Pharmaceuticals | 24 January 1992 |
| 100 tablet in 1 bottle | 64980-438-01 | Rising Pharma Holdings | 10 June 2010 |
| 1000 tablet in 1 bottle | 64980-438-10 | Rising Pharma Holdings | 10 June 2010 |
| 100 tablet in 1 bottle | 0093-0752-01 | Teva Pharmaceuticals | 22 February 1995 |
| 1000 tablet in 1 bottle | 0093-0752-10 | Teva Pharmaceuticals | 22 February 1995 |
| 100 tablet in 1 bottle | 50090-0442-0 | A-S Medication Solutions | 29 June 2016 |
| 30 tablet in 1 bottle | 50090-0442-1 | A-S Medication Solutions | 29 June 2016 |
| 200 tablet in 1 bottle | 50090-0442-7 | A-S Medication Solutions | 29 June 2016 |
| 90 tablet in 1 bottle | 50090-0442-8 | A-S Medication Solutions | 29 June 2016 |
| 100 tablet in 1 bottle | 50090-5363-0 | A-S Medication Solutions | 17 November 2020 |
| 30 tablet in 1 bottle | 50090-5363-1 | A-S Medication Solutions | 19 October 2022 |
| 200 tablet in 1 bottle | 50090-5363-7 | A-S Medication Solutions | 17 November 2020 |
| 90 tablet in 1 bottle | 50090-5363-8 | A-S Medication Solutions | 17 November 2020 |
| 100 tablet in 1 bottle | 50090-5367-0 | A-S Medication Solutions | 18 November 2020 |
| 30 tablet in 1 bottle | 50090-5367-1 | A-S Medication Solutions | 18 November 2020 |
| 200 tablet in 1 bottle | 50090-5367-7 | A-S Medication Solutions | 18 November 2020 |
| 90 tablet in 1 bottle | 50090-5367-8 | A-S Medication Solutions | 18 November 2020 |
| 100 tablet in 1 bottle | 50090-5741-0 | A-S Medication Solutions | 29 September 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 August 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Atenolol 50 mg tablet.
Other strengths and forms of Atenolol
Clinical summary
Atenolol is a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Atenolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AtenololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TENORMIN prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Atenolol 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.